Alzheimer's Disease Trial, Not Yet Recruiting NCT07690865 Sponsor: Chang Gung Memorial Hospital Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Not Yet Recruiting

NCT07690865
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 40 years old.
  • People whose score on a memory and thinking screening test (called the CASI) falls within the normal range for their age and level of education.
  • People with no history of serious brain or mental health conditions — such as stroke, epilepsy, depression, or migraines — that could affect thinking or memory.
  • People who have not taken medications that may affect thinking or memory (such as benzodiazepines or anticholinergic drugs).
  • People with normal vision, or vision that is fully corrected with glasses or contact lenses.
  • People whose brain activity shows a significant response to sound-based stimulation (confirm with trial site).
  • People who report having normal hearing.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have taken part in any study involving cognitive enhancement within the past two months.
  • People with a history of a medical condition that could affect thinking or memory, such as cancer or autoimmune diseases.
  • People who have tinnitus (ringing in the ears) or hyperacusis (heightened sensitivity to sound).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +886-3-211800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2026
Est. completion
1 September 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

changes in neurophysiological function; changes in working memory performance; changes in inhibitory control performance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov